EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting the Microbiota–Metabolism–Immunity Axis: Active Components of Traditional Chinese Medicine in Colitis-Associated Colorectal Cancer

Qiuying Chen, Hanyi Zhang, Lei Fu, Feifei Liu, Qi Yang iD, Guangfa Zhang, Yaozhong Huang, Yanxi Yang, Chun Yao, Yitao Wang, Zhengcai Du, Hua Luo

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27198836 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Qiuying Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Innovative Drug of Traditional Chinese and Zhuang Yao Medicine, Ministry of Education, Guangxi University of Chinese M…. Hauptthemen laut MEDLINE: Medicine, Chinese Traditional, Colitis-Associated Neoplasms, Gastrointestinal Microbiome, Drugs, Chinese Herbal. Die Arbeit nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Administration of Traditional Chinese Medicine–Guangxi Joint Special Project for the Inheritance, Innovation and Development of TCM Science and Techno…, Guangxi University of Chinese Medicine Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colitis-associated colorectal cancer (CAC) develops in the setting of long-standing intestinal inflammation and remains a major complication of inflammatory bowel disease (IBD). Although effective control of inflammation may reduce cancer risk, approaches that specifically prevent the progression from chronic colitis to neoplasia remain limited. Disruption of the gut microbiota–metabolism–immunity axis is increasingly implicated in this process, as microbial dysbiosis and altered metabolite production can compromise epithelial barrier integrity, sustain inflammatory signaling, and disturb mucosal immune homeostasis. This review examines how active components derived from traditional Chinese medicine (TCM), particularly flavonoids, alkaloids, saponins, and polysaccharides, influence this interconnected network in CAC-related models. Rather than treating these constituents as a single group, we compare the mechanistic patterns and evidence base associated with each class. Flavonoids and alkaloids have been studied mainly in relation to inflammatory signaling and epithelial barrier protection, whereas saponins are more often linked to regulation of the immune microenvironment. Polysaccharides have been studied most frequently in relation to microbiota remodeling, short-chain fatty acid production, and mucosal immune balance. These distinctions are not absolute, and substantial overlap exists across component classes. Moreover, most evidence is derived from animal or cell-based studies, with marked variation in experimental models, compound characterizations, dosing, and outcome assessments. The microbiota–metabolism–immunity axis provides a coherent framework for interpreting the multi-level actions of TCM-derived components, but their causal mechanisms and clinical relevance to human CAC require further validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medicine, Chinese TraditionalColitis-Associated NeoplasmsGastrointestinal MicrobiomeDrugs, Chinese HerbalColitisColorectal NeoplasmsHumansAnimalsIntestinal Barrier Function

Stichwörter der Autor:innen

colitis-associated colorectal cancergut microbiotaimmune regulationshort-chain fatty acidstraditional Chinese medicine

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Engineering Research Center of Innovative Drug of Traditional Chinese and Zhuang Yao Medicine, Ministry of Education, Guangxi University of Chinese Medicine, Nanning 530200, China.
  • Institute of Traditional Chinese and Zhuang-Yao Ethnic Medicine, Guangxi University of Chinese Medicine, Nanning 530200, China.
  • Foshan Joint Key Laboratory for the Research and Development and Industrialization of Chinese Medicinal Formulations, Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Foshan 528000,…

ORCID-Profile: Qi Yang

Förderung

  • National Natural Science Foundation of China
  • National Administration of Traditional Chinese Medicine–Guangxi Joint Special Project for the Inheritance, Innovation and Development of TCM Science and Techno…
  • Guangxi University of Chinese Medicine Foundation
  • Joint Laboratory for R&D and Transformation of Traditional Chinese Medicine Preparations
  • Program for Innovative Talents of the National Natural Science Foundation of China
  • Guangxi Young Elite Scientist Sponsorship Program

Zitieren

APA

Chen, Q., Zhang, H., Fu, L., Liu, F., Yang, Q., Zhang, G., Huang, Y., Yang, Y., Yao, C., Wang, Y., Du, Z., & Luo, H. (2026). Targeting the Microbiota–Metabolism–Immunity Axis: Active Components of Traditional Chinese Medicine in Colitis-Associated Colorectal Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198836

Vancouver

Chen Q, Zhang H, Fu L, Liu F, Yang Q, Zhang G, et al. Targeting the Microbiota–Metabolism–Immunity Axis: Active Components of Traditional Chinese Medicine in Colitis-Associated Colorectal Cancer. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198836

BibTeX
@article{Chen2026,
  author = {Chen, Qiuying and Zhang, Hanyi and Fu, Lei and Liu, Feifei and Yang, Qi and Zhang, Guangfa and Huang, Yaozhong and Yang, Yanxi and Yao, Chun and Wang, Yitao and Du, Zhengcai and Luo, Hua},
  title = {Targeting the Microbiota–Metabolism–Immunity Axis: Active Components of Traditional Chinese Medicine in Colitis-Associated Colorectal Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27198836}
}
Kostenlos starten →